SVR12 was achieved by 97.2% (490 of 504) of patients with cirrhosis (95.8–98.0% with DCV + SOF ± RBV; 95.7–97.3% with LDV/SOF ± RBV; 90.9–100% with SOF/VEL ± RBV), 94.6% (156 of 165) of cirrhosis patients with platelet counts < 100 × 109/L, 94.5% (137 of 145) of those with albumin < 3.5 g/dL and 92.8% (129 of 139) of those with total bilirubin ≥1.2 mg/dL. Here, ALB is linked to Cirrhosis.